 MARINA DEL REY, Calif., Aug. 2, 2021 PRNewswire -- Armata Pharmaceuticals, Inc. NYSE American: ARMP Armata, us, our, or the Company, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that its current Chief Executive Officer, Todd R. 